We are live on ! Find out more
FBIOP icon

Fortress Biotech 9.375% Series A Preferred Stock
FBIOP

1 hedge funds and large institutions have $966K invested in Fortress Biotech 9.375% Series A Preferred Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.53% more ownership

Funds ownership: 0% → 1.53% (+1.5%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
1
Shikiar Asset Management
New York
$966K +$1.02M +52,500 New

FBIOP Hedge Fund Activity: Q1 2023 in Review

1 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech 9.375% Series A Preferred Stock (FBIOP) for Q1 2023, worth a combined $966K.

Buyers outnumbered sellers: 1 fund opened new FBIOP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Fortress Biotech 9.375% Series A Preferred Stock (FBIOP) as of Q1 2023, up from 0 in Q4 2022.
  • Funds reported $966K of Fortress Biotech 9.375% Series A Preferred Stock stock for Q1 2023.
  • 1 fund opened new Fortress Biotech 9.375% Series A Preferred Stock positions in Q1 2023 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q1 2023.